Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian Cancer
NCT00247988Phase 2Terminated
- Sponsor
- University of Saskatchewan
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in ovarian cancer, fallopian tube carcinoma (PFTC) and primary peritoneal cancer (PPC), sponsored by University of Saskatchewan. Primary endpoint: Objective Response Rate. Started Oct 2003; status: terminated.
02
Drugs
docetaxel
03
Conditions
ovarian cancerfallopian tube carcinoma (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00247988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00247988.